Ingrid Rechtin

Ingrid Rechtin practices in the firm’s corporate group.  Before joining the San Francisco office, she was resident in the firm’s New York office.  Her corporate experience includes public and private mergers and acquisitions, securities, finance and general corporate matters.

Representative Matters

• bioMérieux S.A., a global provider of in vitro diagnostics, in connection with its $60 million acquisition of AviaraDx, a molecular diagnostics and theranostics company.
• The Charles Schwab Corporation in its acquisition of Etelligent Consulting, Inc., a leading provider of technology and back office services to registered investment advisors.
• Paramount Acquisition Corp., a healthcare focused special purpose acquisition company, in its acquisition of Chem Rx, a leading institutional pharmacy.
• Oregon Steel Mills, Inc., in its $2.3 billion merger into Evraz Group S.A.
• Abbott Laboratories, in its $3.7 billion acquisition of Kos Pharmaceuticals, Inc.
• Kerr-McGee Corporation, in its $18 billion merger into Anadarko Petroleum Corporation.

Honors and Rankings

• Legal Aid Society 2004 Pro Bono Award

Publications and Speeches

• "California Supreme Court Affirms Limitations on NonCompetition Covenants," Covington E-Alert (11/17/2008), Co-Author
• "Company Web Sites and the Securities Laws," Covington Advisory (8/22/2008), Co-Author